Biotech & Health Tech
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗